Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-6830

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-6830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing mean severity of day heartburn by study day for evaluable patients. The graph compares placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD over 60 days from the start of treatment, with severity levels ranging from 0 (none) to 3 (severe).*

FDA Label Image

Figure2 (Figure2)

A line graph illustrating the mean severity of night heartburn over 60 days from the start of treatment. The Y-axis ranges from 0 (None) to 3 (Severe), and the X-axis shows days from start of treatment. Three groups are compared: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with the latter showing the greatest reduction in heartburn severity.*

FDA Label Image

Label Image (Lbl500906830)

Packaging label for Lansoprazole delayed-release capsules, 30 mg, manufactured by A-S Medication Solutions. The label indicates a bottle containing 90 capsules, with storage instructions to keep at 68 to 77 degrees Fahrenheit and to protect from moisture.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole shown as a molecular diagram illustrating its atomic and bond arrangement. This image depicts the chemical structure corresponding to the active ingredient lansoprazole used in oral delayed-release capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.